Kobo Biotech Ratios

Kobo Biotech Ltd Ratios

The Kobo Biotech Ltd Ratios page provides a complete fundamental analysis of Kobo Biotech Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Kobo Biotech Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Kobo Biotech Ltd (NSE: , BSE: 531541) is currently trading at ₹2.54, with a market capitalization of ₹58.85M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Kobo Biotech Ltd remains a key stock for fundamental analysis using Kobo Biotech Ltd Ratios.

Kobo Biotech Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Kobo Biotech Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Kobo Biotech Ltd Ratios.

Historically, the Kobo Biotech Ltd P/E ratio has shown strong fluctuations:

The decline in Kobo Biotech Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Kobo Biotech Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Kobo Biotech Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Kobo Biotech Ltd P/S ratio currently stands at 0, an important part of Kobo Biotech Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Kobo Biotech Ltd P/S ratio indicates cautious market sentiment.

Kobo Biotech Ltd Price to Cash Flow Ratio (P/CF)

The Kobo Biotech Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Kobo Biotech Ltd Price to Cash Flow Ratio:

The declining Kobo Biotech Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Kobo Biotech Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Kobo Biotech Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Kobo Biotech Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Kobo Biotech Ltd EV/EBITDA ratio is currently 0, a key metric in Kobo Biotech Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Kobo Biotech Ltd EV/EBITDA indicates balanced valuation.

Kobo Biotech Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Kobo Biotech Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Kobo Biotech Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Kobo Biotech Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Kobo Biotech Ltd Ratios Analysis Summary

The Kobo Biotech Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Kobo Biotech Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Kobo Biotech Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.